医学
重症肌无力
胸腺切除术
疾病
重症监护医学
免疫学
内科学
作者
Mohammed Alhaidar,Sumayyah K. Abumurad,Betty C. Soliven,Kourosh Rezania
摘要
Myasthenia gravis (MG) is the most extensively studied antibody-mediated disease in humans. Substantial progress has been made in the treatment of MG in the last century, resulting in a change of its natural course from a disease with poor prognosis with a high mortality rate in the early 20th century to a treatable condition with a large proportion of patients attaining very good disease control. This review summarizes the current treatment options for MG, including non-immunosuppressive and immunosuppressive treatments, as well as thymectomy and targeted immunomodulatory drugs.
科研通智能强力驱动
Strongly Powered by AbleSci AI